In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone (Q35248737)

7 August 2017

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone (English)

1 reference

7 August 2017

1

Jones RN

1 reference

7 August 2017

2

Barry AL

1 reference

PubMed ID

2327779

7 August 2017

language of work or name

English

0 references

publication date

1 February 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

1 reference

7 August 2017

34

1 reference

7 August 2017

2

1 reference

7 August 2017

306-313

1 reference

Method of reliable determination of minimal lethal antibiotic concentrations

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

In vitro activity of PD 127,391, an enhanced-spectrum quinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171578

Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolones

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2327779

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.2.306

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

PubMed ID

2327779